Does Cytomegalovirus Cause Proctitis?
Yes, cytomegalovirus (CMV) definitively causes proctitis, but almost exclusively in immunocompromised patients—particularly those with HIV/AIDS or other forms of severe immunosuppression. 1
Clinical Context and Patient Populations
CMV causes proctocolitis rather than isolated proctitis in most cases. The key distinction is critical:
True proctitis (limited to distal 10-12 cm of rectum) is typically caused by N. gonorrhoeae, C. trachomatis, T. pallidum, and HSV in sexually active individuals 2
CMV causes proctocolitis, which extends beyond 12 cm and presents with symptoms of proctitis PLUS diarrhea and abdominal cramps 1, 2
Immunocompromised Patients (Primary Population)
CMV proctocolitis occurs predominantly in immunosuppressed HIV-infected patients as an opportunistic infection 1. The CDC guidelines consistently categorize CMV as causing proctocolitis in this population, not isolated proctitis. Other high-risk groups include:
- Solid organ transplant recipients (4.9% 10-year cumulative incidence post-liver transplant) 3
- Hematopoietic stem cell transplant recipients (15-25% incidence) 3
- Patients on chronic immunosuppression for inflammatory bowel disease 4
Immunocompetent Patients (Rare but Emerging Recognition)
Recent case reports from 2023-2025 demonstrate that CMV proctitis can occur in immunocompetent elderly patients with comorbidities (diabetes, advanced age) 5, 6, 7. This represents an underrecognized presentation that can mimic inflammatory bowel disease or malignancy. However, these remain exceptional cases rather than the typical presentation.
Diagnostic Approach
When evaluating for CMV proctocolitis in at-risk patients:
Perform colonoscopy/sigmoidoscopy looking for:
Obtain tissue biopsy (essential):
Consider CMV PCR on blood or tissue for viral load assessment 4
Critical Clinical Pitfall
Do not empirically treat suspected sexually transmitted proctitis with standard regimens (ceftriaxone + doxycycline) if the patient is immunocompromised. 2 In HIV-positive patients or other immunosuppressed individuals presenting with proctocolitis symptoms, CMV must be in the differential and requires endoscopic evaluation with biopsy before initiating therapy.
Treatment Implications
CMV proctocolitis requires antiviral therapy (ganciclovir 5 mg/kg IV twice daily for 5-10 days, then valganciclovir 900 mg daily for 2-3 weeks total) 4, not antibiotics. In severe cases with perforation or toxic megacolon, surgical intervention may be necessary, but medical management is preferred 3.
The mortality rate is significant if misdiagnosed—emphasizing the importance of considering CMV in the appropriate clinical context 3.